Regenerative Medical Technology Empowers Burn Care: MEBO International Shines at the 2026 ABA Orlando Conference

Regenerative Medical Technology Empowers Burn Care: MEBO International Shines at the 2026 ABA Orlando Conference

The 58th Annual Meeting of the American Burn Association (ABA) took place in Orlando from April 14 to 17, 2026. In the opening presentation, ABA President Jeffrey Carter emphasized that innovation, collaboration, and humanistic care are the key drivers advancing burn treatment — a vision closely aligned with MEBO International's commitment to driving technological breakthroughs through regenerative medicine and improving patient outcomes.

As a global leader in regenerative medicine, MEBO International has attended the ABA Annual Meeting for many consecutive years. This year, the company once again systematically presented its full-process wound care solutions. Notably, for the first time at its booth, MEBO International unveiled the achievements of its APEC collaboration, spotlighting its leading role and outstanding contributions to burn care across the APEC region since 2023.

Regenerative Medical Technology Empowers Burn Care: MEBO International Shines at the 2026 ABA Orlando Conference

In 2023, the APEC Burn Symposium initiated by Kevin Xu — Chairman of the APEC 2023 Host Committee and Chairman of MEBO International — was successfully held, bringing together leading burn care experts from APEC member economies including China, the United States, Canada, Australia, and Mexico to jointly address critical issues in global burn treatment.

During the conference, Dr. Ariel Miranda, President-Elect of the International Society for Burn Injuries (ISBI), visited MEBO International booth and formally invited MEBO to serve as a key partner in the society's preparation and organization — reflecting the international academic community's strong recognition of MEBO's global influence.

Regenerative Medical Technology Empowers Burn Care: MEBO International Shines at the 2026 ABA Orlando Conference

Moist Exposed Burn Ointment is currently undergoing FDA clinical trials for burn treatment in the United States, with the Burn Center at the University of California, Davis among the participating sites. The center's expert team shared updates at the booth: clinical results to date have demonstrated excellent therapeutic outcomes, particularly in wound healing, pain relief, and scar prevention, receiving positive feedback from both investigators and patients.

This year's annual meeting further deepened the strategic cooperation between MEBO International and the ABA. The two parties will continue collaborating in technology promotion, clinical research, and education and training, accelerating the global application of regenerative medical technology.

This story was adapted from the original release published on mebo.education.